MOMM Diagnostics specializes in the development of an in-vitro diagnostic test for the early diagnosis of preeclampsia.
MOMM Diagnostics has raised $500K in total funding. The most recent round was Grant. The last funding was announced in October 2025.
MOMM Diagnostics's investors include Bill & Melinda Gates Foundation, Venture Kick.
MOMM Diagnostics is headquartered in Basel, Switzerland.
MOMM Diagnostics specializes in the development of an in-vitro diagnostic test for the early diagnosis of preeclampsia.
MOMM Diagnostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MOMM Diagnostics — Funding & Investors." VCBacked, October 5, 2025, https://www.vcbacked.co/company/momm-diagnostics. Accessed August 16, 2026.
VCBacked. (2025). MOMM Diagnostics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/momm-diagnostics
{{cite web |title=MOMM Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/momm-diagnostics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated